Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is Scopus-indexed (Q3, CiteScore 3.5). Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2167-9436Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 148 / 234 | 36th | Q3 |
| Immunology | 161 / 243 | 33rd | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q3, CiteScore 3.5.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is Q3 in Immunology and Allergy (rank 148 of 234) and Q3 in Immunology (rank 161 of 243), by CiteScore 2025.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.5, quartile Q3, 36th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.254, quartile Q4, with an H-index of 44.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is published by SAGE Publications Ltd. Its ISSN is 2167-9436.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy has an h-index of 34 and a 2-year mean of 1.74 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q3. On 2-year citations it ranks #133 of 231 Scopus journals in Immunology and Allergy.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy published 16 papers in 2025; its busiest recent year was 2022 with 58. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2022–2026), authors are most often from Japan (62.8%), United States (12.8%) and Brazil (5.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.